Denials Are Escalating. Here’s How Revenue Cycle Leaders Are Fighting Back
As payers use more automation and AI, a HealthLeaders panel looks at how providers can close the technology gap, expand automated appeals, and move to a proactive approach.
This article explores the shift toward personalized care through the end-stage kidney disease (ESKD) Life-Plan framework, highlighting how arteriovenous (AV) grafts are emerging as a timely, patient-centered option — especially for those who need urgent dialysis or lack suitable vessels for fistulas.
Denials are not only continuing but also changing. What used to be a manual process between providers and payers has become a technology-driven challenge, using automation, pattern recognition, and a large language model (LLM) powered clinical review. At a recent HealthLeaders webinar titled “The Winning Edge for Defeating Denials,” sponsored by Aspirion, industry leaders discussed how health systems are adapting.
Sponsored by
Download Your Complimentary Copy